Great News- Fda approves TAVR for low-risk patients after two successful clinical trials

The full story is here. I’ve previously discussed the breakthrough TAVR procedure for aortic stenosis where the new valve is deployed through the groin. This is minimally invasive, does not involve opening the chest, and does not require the patient to be on a heart-lung machine. Clinical trials have shown good results, with faster recovery time than the “old-school” surgery. Medicare will also pay for the new procedure. This is great news for anyone with severe aortic stenosis that needs a replacement valve. Previously the procedure had been approved only for patients at intermediate or high risk from the traditional procedure.

Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s